Instead, the newly identified erythroblastic oncogene B (ERBB) and janus kinase-signal transducer and activator of transcription protein (JAK-STAT) signaling pathways could unveil new mechanisms involved in MVP progression. This evidence concerns the gene EGFR and familial mitral valve prolapse.